Eli Lilly & Co
LLY· NYSE
Released Oct 30, 2015
10-Q filed Oct 30, 2015, 30 days after period end · 0000059478-15-000175
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $4.96B | $4.88B | $5.77B | $5.44B |
| Net Income | $799.70M | $500.60M | $1.20B | $1.33B |
| EPS Diluted | $0.75 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $0.47 |
| $1.11 |
| $1.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.